EuroPCR 2022: Late-breaking Science Video Collection
Published: 13 May 2022
-
Views:
2471 -
Likes:
7
-
Views:
2471 -
Likes:
7
-
Up Next
-
27m 14sPart 1 | Session 2 EuroPCR 22 Late-breaking Science Wrap-Up
-
3m 28sPart 2 | Session 1 EuroPCR 22: AQVA Study Shows Superiority in QFR-Based Virtual PCI Arm
-
5m 10s
-
7m 50s
-
5m 56s
-
3m 34sPart 2 | Session 5 EuroPCR 22: CRUZ-HBR Indicates Use Of Supraflux™ Cruz Stent Is Favourable
-
4m 49s
-
3m 53sPart 2 | Session 7 EuroPCR 22: Short-Term Clinical Outcomes of ACURATE neo2™
-
4m 20s
-
2m 18sPart 2 | Session 9 EuroPCR 22: SYNERGY™ Non-inferior to BioMatrix NeoFlex in OCT SORT-OUT VIII
-
5m 9s
-
7m 18sPart 2 | Session 11 EuroPCR 22: Balloon Vs Self-Expanding Valves in Valve-in-Valve TAVI
-
5m 52sPart 2 | Session 12 EuroPCR 22: MitraClip in Atrial Functional Mitral Regurgitation
-
2m 15sPart 2 | Session 13 EuroPCR 22: SCB with Micro-Reservoir Technology in Coronary Lesions
-
4m 46sPart 2 | Session 14 EuroPCR 22: FORWARD PRO Study Shows No Durability Issues After 3 Years
-
4m 25sPart 2 | Session 15 EuroPCR 22: DEB & DES in the Treatment of Diffuse CAD
-
3m 16sPart 2 | Session 16 EuroPCR 22: EASTBOURNE Registry indicates Satefy of Sirolimus-Coated Balloon
-
4m 27sPart 2 | Session 17 EuroPCR 22: JenaValve TAVR System for the Treatment of Aortic Regurgitation
-
7m 7sPart 2 | Session 18 EuroPCR 22: Transcatheter Tricuspid Valve Repair with PASCAL System
-
6m 53s
Overview
Our regular review series View from the Thoraxcenter hosted by Prof Nicolas Van Mieghem and Dr Joost Daemen (Thoraxcentre, Erasmus MC, Rotterdam, NL) provide a concise analysis of the late-breaking science trials and spotlight questions that could change treatment strategies in interventional cardiology.
Short, accessible Expert Interviews will be available with select faculty focusing on the results, applicability, and impact on future research.
More from this programme
Part 1
View from the Thoraxcenter
Part 2
Expert Interviews
Faculty Biographies
Joost Daemen
Interventional Cardiologist
Dr Joost Daemen, MD, PhD is a senior interventional cardiologist at the Thorax Center, Erasmus MC, Rotterdam, NL. Dr Daemen obtained his degree in medicine at the Erasmus University Medical Center, Rotterdam in 2005 and did 2 years of internal medicine training and 4 years of general cardiology training at the Thoraxcenter, Rotterdam.
Dr Daemen is actively involved in several drug-eluting stent trials and is Principal Investigator of four trials focusing on the safety and efficacy of renal sympathetic denervation in hypertension, heart failure, vasospastic angina and heart failure. Dr Daemen is a member of the editorial board of EuroIntervention and the Netherlands Heart Journal, member of Young ICIN, and has completed courses in biomedical statistics and device training.
Nicolas M Van Mieghem
Medical Director
Prof Nicolas Maria Van Mieghem is an Interventional cardiologist at Thoraxcenter, Erasmus MC, Rotterdam, NL decided to pursue a career that would help others. “I enjoy the feeling of being able to help someone or do something important for them". His father was a general cardiologist and one of his biggest influences early in his career.
Prof Van Mieghem initially intended to train as a cardiac surgeon but decided to specialise in interventional cardiology instead, following advice from a mentor. This decision was cemented when he read the first-in-human case report of transcatheter aortic valve implantation (TAVI) in Circulation by Alain Cribier in 2002. Prof Van Mieghem believes that great cardiologist genuinely cares for their patients. He names Gary Roubin, Dr Manu Malbrain and Professor Patrick Serruys among his mentors.
His current research focuses on cerebral embolic protection during TAVI and the search for improved…